NCT00740857

Brief Summary

This is a study of healthy volunteers to compare how quickly different ibuprofen products relieve dental pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
211

participants targeted

Target at P75+ for phase_4 pain

Timeline
Completed

Started Aug 2008

Shorter than P25 for phase_4 pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

August 22, 2008

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 25, 2008

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2008

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

August 12, 2010

Completed
Last Updated

June 6, 2011

Status Verified

June 1, 2011

Enrollment Period

3 months

First QC Date

August 22, 2008

Results QC Date

October 30, 2009

Last Update Submit

June 1, 2011

Conditions

Keywords

Dental pain analgesia

Outcome Measures

Primary Outcomes (1)

  • Time to Meaningful Pain Relief

    Subjects evaluated the time to "First Perceptible" Relief by depressing a stopwatch at the moment they first began to experience "perceptible" relief and the time to "Meaningful" Relief by depressing a second stopwatch at the moment they first began to experience "meaningful" relief. These times were recorded up to 6 hrs after dosing. Range: up to 6 hrs, a lower number is better.

    0-6 hours

Secondary Outcomes (7)

  • Pain Intensity Difference (PID) Scores at Each Individual Time Points

    0-6 hours

  • Pain Relief (PR) Scores at Individual Time Points

    0-6 hours

  • Time-weighted Sum of Pain Relief + Pain Intensity Difference (SPRID) From 0-2 Hours and 0-6 Hours

    0-2 and 0-6 hours

  • Pain Relief Combined With Pain Intensity Difference (PRID) Scores at Individual Time Points

    0-6 hours

  • Time-weighted Sum of Pain Intensity Difference (SPID) From 0-2 Hours and 0-6 Hours

    0-2 and 0-6 hours

  • +2 more secondary outcomes

Study Arms (3)

1

PLACEBO COMPARATOR
Drug: placebo

2

ACTIVE COMPARATOR
Drug: ibuprofen Formulation 1

3

ACTIVE COMPARATOR
Drug: ibuprofen Formulation 2

Interventions

2 placebo gels capsules delivered as a single dose.

1

2 marketed ibuprofen gels

2

2 marketed ibuprofen gels

3

Eligibility Criteria

Age16 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Outpatients with post-operative pain following surgical extraction of third molars,
  • examined by the attending dentist or physician and medically cleared to participate in the study,
  • in general good health and have no contraindications to the study or rescue medication.
  • any serious medical condition,
  • acute localized dental infection at the time of surgery ,
  • females who are pregnant, lactating, of child-bearing potential, or post-menopausal for less than 2 years and not using a medically approved method of contraception.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Salt Lake City, Utah, 84124, United States

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
U. S. Contact Center
Organization
Wyeth

Study Officials

  • Medical Monitor

    Wyeth is now a wholly owned subsidiary of Pfizer

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

August 22, 2008

First Posted

August 25, 2008

Study Start

August 1, 2008

Primary Completion

November 1, 2008

Study Completion

November 1, 2008

Last Updated

June 6, 2011

Results First Posted

August 12, 2010

Record last verified: 2011-06

Locations